[1] |
Hoque MR, Haque E, Karim MR. Cervical cancer in low-income countries: a Bangladeshi perspective[J]. Int J Gynaecol Obstet, 2021, 152(1): 19-25. DOI: 10.1002/ijgo.13400.
|
[2] |
Wang R, Pan W, Jin L, et al. Human papillomavirus vaccine against cervical cancer: opportunity and challenge[J]. Cancer Lett, 2020, 471: 88-102. DOI: 10.1016/j.canlet.2019.11.039.
|
[3] |
Chen L, Wang C, Sun H, et al. The bioinformatics toolbox for circRNA discovery and analysis[J]. Brief Bioinform, 2021, 22(2): 1706-1728. DOI: 10.1093/bib/bbaa001.
|
[4] |
Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs[J]. Mol Cell, 2018, 71(3): 428-442. DOI: 10.1016/j.molcel.2018.06.034.
|
[5] |
Tran AM, Chalbatani GM, Berland L, et al. A new world of biomarkers and therapeutics for female reproductive system and breast cancers: circular RNAs[J]. Front Cell Dev Biol, 2020, 8: 50. DOI: 10.3389/fcell.2020.00050.
|
[6] |
Huang J, Zhou Q, Li Y. Circular RNAs in gynecological disease: promising biomarkers and diagnostic targets[J]. Biosci Rep, 2019, 39(5): BSR20181641. DOI: 10.1042/BSR20181641.
|
[7] |
Xu S, Zhou L, Ponnusamy M, et al. A comprehensive review of circRNA: from purification and identification to disease marker potential[J]. Peer J, 2018, 6: e5503. DOI: 10.7717/peerj.5503.
|
[8] |
Tang X, Ren H, Guo M, et al. Review on circular RNAs and new insights into their roles in cancer[J]. Comput Struct Biotechnol J, 2021, 19: 910-928. DOI: 10.1016/j.csbj.2021.01.018.
|
[9] |
Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs[J]. Nat Rev Mol Cell Biol, 2020, 21(8): 475-490. DOI: 10.1038/s41580-020-0243-y.
|
[10] |
Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges[J]. Nature, 2013, 495(7441): 384-388. DOI: 10.1038/nature11993.
|
[11] |
|
[12] |
Chen L, Zhang S, Wu J, et al. circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family[J]. Oncogene, 2017, 36(32): 4551-4561. DOI: 10.1038/onc.2017.89.
|
[13] |
Chen J, Yang J, Fei X, et al. CircRNA ciRS-7: a novel oncogene in multiple cancers[J]. Int J Biol Sci, 2021, 17(1): 379-389. DOI: 10.7150/ijbs.54292.
|
[14] |
Li H, Lan M, Liao X, et al. Circular RNA cir-ITCH promotes osteosarcoma migration and invasion through cir-ITCH/miR-7/EGFR pathway[J]. Technol Cancer Res Treat, 2020, 19: 1533033819898728. DOI: 10.1177/1533033819898728.
|
[15] |
Yang CD, Yuan WB, Yang X, et al. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression[J]. Mol Cancer, 2018, 17(1): 19. DOI: 10.1186/s12943-018-0771-7.
|
[16] |
Patop IL, Wust S, Kadener S, et al. Past, present, and future of circRNAs[J]. EMBO J, 2019, 38(16): e100836. DOI: 10.15252/embj.2018100836.
|
[17] |
Chen Y, Lin Y, Shu Y, et al. Interaction between N 6-methyladenosine (m 6A) modification and noncoding RNAs in cancer[J]. Mol Cancer, 2020, 19(1): 94. DOI: 10.1186/s12943-020-01207-4.
|
[18] |
Legnini I, Di Timoteo G, Rossi F, et al.Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis[J]. Mol Cell, 2017, 66(1): 22-37. DOI: 10.1016/j.molcel.2017.02.017.
|
[19] |
Yang Y, Gao X, Zhang M, et al. Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis[J]. J Natl Cancer Inst, 2018, 110(3): 304-315. DOI: 10.1093/jnci/djx166.
|
[20] |
Zhang M, Huang N, Yang X, et al. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis[J]. Oncogene, 2018, 37(13): 1805-1814. DOI: 10.1038/s41388-017-0019-9.
|
[21] |
Lei M, Zheng G, Ning Q, et al. Translation and functional roles of circular RNAs in human cancer[J]. Mol Cancer, 2020, 19(1): 30. DOI: 10.1186/s12943-020-1135-7.
|
[22] |
Chaichian S, Shafabakhsh R, Mirhashemi SM, et al. Circular RNAs: a novel biomarker for cervical cancer[J]. J Cell Physiol, 2020, 235(2): 718-724. DOI: 10.1002/jcp.29009.
|
[23] |
Zang J, Lu D, Xu A. The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function[J]. J Neurosci Res, 2020, 98(1): 87-97. DOI: 10.1002/jnr.24356.
|
[24] |
Salzman J. Circular RNA expression: its potential regulation and function[J]. Trends Genet, 2016, 32(5): 309-316. DOI: 10.1016/j.tig.2016.03.002.
|
[25] |
Li Y, Ge YZ, Xu L, et al. Circular RNA ITCH: a novel tumor suppressor in multiple cancers[J]. Life Sci, 2020, 254: 117176. DOI: 10.1016/j.lfs.2019.117176.
|
[26] |
Tornesello ML, Faraonio R, Buonaguro L, et al. The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer[J]. Front Oncol, 2020, 10: 150. DOI: 10.3389/fonc.2020.00150.
|
[27] |
Yeo-teh NSL, Ito Y, Jha S. High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis[J]. Int J Mol Sci, 2018, 19(6): 1706. DOI: 10.3390/ijms19061706.
|
[28] |
Zheng SR, Zhang HR, Zhang ZF, et al. Human papillomavirus 16 E7 on coprotein alters the expression profiles of circular RNAs in Caski cells[J]. J Cancer, 2018, 9(20): 3755-3764. DOI: 10.7150/jca.24253.
|
[29] |
Yu L, Zheng ZM. Human papillomavirus type 16 circular RNA is barely detectable for the claimed biological activity[J]. mBio, 2022, 13(1): e0359421. DOI: 10.1128/mbio.03594-21.
|
[30] |
Zhao J, Lee EE, Kim J, et al.Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus[J]. Nature Communications, 2019, 10(1): 2300. DOI: 10.1038/s41467-019-10246-5.
|
[31] |
Jiao J, Zhang T, Jiao X, et al. Hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion[J]. J Cell Physiol, 2020, 235(2): 1287-1295. DOI: 10.1002/jcp.29045.
|
[32] |
Kourtidis A, Lu R, Pence LJ, et al. A central role for cadherin signaling in cancer[J]. Exp Cell Res, 2017, 358(1): 78-85. DOI: 10.1016/j.yexcr.2017.04.006.
|
[33] |
Daulagala AC, Bridges MC, Kourtidis A. E-cadherin beyond structure: a signaling hub in colon homeostasis and disease[J]. Int J Mol Sci, 2019, 20(11): 2756. DOI: 10.3390/ijms20112756.
|
[34] |
Ma L, Yang R, Gu J, et al. The expression of AGGF1, FOXC2, and E-cadherin in esophageal carcinoma and their clinical significance[J]. Medicine (Baltimore), 2020, 99(37): e22173. DOI: 10.1097/MD.0000000000022173.
|
[35] |
He J, Lyu X, Zeng Z. A potential disease monitoring and prognostic biomarker in cervical cancer patients: the clinical application of circular RNA_0018289[J]. J Clin Lab Anal, 2020, 34(8): e23340. DOI: 10.1002/jcla.23340.
|
[36] |
Gao YL, Zhang MY, Xu B, et al. Circular RNA expression profiles reveal that hsa_circ_0018289 is up-regulated in cervical cancer and promotes the tumorigenesis[J]. Oncotarget, 2017, 8(49): 86625-86633. DOI: 10.18632/oncotarget.21257.
|
[37] |
Wang J, Li H, Liang Z. circ-MYBL2 serves as a sponge for miR-361-3p promoting cervical cancer cells proliferation and invasion[J]. Onco Targets Ther, 2019, 12: 9957-9964. DOI: 10.2147/OTT.S218976.
|
[38] |
Wang Y, Wang L, Wang W,et al.Overexpression of circular RNA hsa_circ_0001038 promotes cervical cancer cell progression by acting as a ceRNA for miR-337-3p to regulate cyclin-M3 and metastasis-associated in colon cancer 1 expression[J]. Gene, 2020, 733: 144273. DOI: 10.1016/j.gene.2019.144273.
|
[39] |
Ma H, Tian T, Liu X, et al. Upregulated circ_0005576 facilitates cervical cancer progression via the miR-153/KIF20A axis[J]. Biomed Pharmacother, 2019, 118: 109311. DOI: 10.1016/j.biopha.2019.109311.
|